Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Zhenxiang Hu"'
Publikováno v:
Electronic Journal of Differential Equations, Vol 2023, Iss 08,, Pp 1-38 (2023)
Externí odkaz:
https://doaj.org/article/211191b3264643a09997e9df7c880b1b
Autor:
Xuezhi Cao, Yong Liang, Zhenxiang Hu, Huiyu Li, Jiaming Yang, Eric J. Hsu, Jiankun Zhu, Jin Zhou, Yang-Xin Fu
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Several studies have demonstrated that IFN-I administration can boost anti-tumor immune response against solid tumors. Here, to overcome the limitations of systemic IFN-I therapy (side effects, short half-life), the authors design a masked IFN-I prod
Externí odkaz:
https://doaj.org/article/8b56982268c24d6785de4d9f98953a35
Autor:
Shiyu Sun, Xi Chen, Jingjing Lin, Junwen Ai, Jiaming Yang, Zhenxiang Hu, Yang-Xin Fu, Hua Peng
Publikováno v:
Cell Discovery, Vol 7, Iss 1, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/9e6acf057c5f4eaf85e7d5b7cd3f79d4
Autor:
Qiaren He, Shiyu Sun, Xi Chen, Zhenxiang Hu, Yan Zhang, Hua Peng, Yang-Xin Fu, Jiaming Yang, Long Chen
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 1; Pages: 146
A fourth dose of a COVID-19 vaccine has been recommended by a number of authorities due to waning immunity over time and the emergence of immune-escaping variants. Here, we evaluated the safety and immunogenicity of the bivalent BV-01-B5 or V-01D-351
Autor:
Qiang, Ma, Wenji, Ma, Tian-Zhang, Song, Zhaobo, Wu, Zeyuan, Liu, Zhenxiang, Hu, Jian-Bao, Han, Ling, Xu, Bo, Zeng, Bosong, Wang, Yinuo, Sun, Dan-Dan, Yu, Qian, Wu, Yong-Gang, Yao, Yong-Tang, Zheng, Xiaoqun, Wang
Publikováno v:
Zoological research. 43(6)
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes diverse clinical manifestations and tissue injuries in multiple organs. However, cellular and molecular understanding of SARS-CoV-2 infection-associated pathology and
Autor:
Huiyu Li, Jiankun Zhu, Yang Xin Fu, Eric Hsu, Xuezhi Cao, Jin Zhou, Zhenxiang Hu, Yong Liang, Jiaming Yang
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Nature Communications
Nature Communications
Type I interferon is promising in treating different kinds of tumors, but has been limited by its toxicity, lack of tumor targeting, and very short half-life. To target tumors, reduce systemic toxicity, and increase half-life, here we engineer a mask
Autor:
Pu Gao, Chaoyang Meng, Hua Peng, Yifan Lin, Yang Pu, Fang Zhao, Yang Xin Fu, Yueqi Cai, Haibin Huang, Tian-Zhang Song, Yu Gao, Zhenxiang Hu, Silin Zhang, Jing Sun, Hairong Xu, Yalan Zhu, Lin Cheng, Dan-Dan Yu, Yong-Tang Zheng, Jian-Bao Han, Shiyu Sun, Xiao-Li Feng, Zheng Zhang, Haidong Tang, Jincun Zhao, Jiaming Yang
Publikováno v:
Cell Research
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding do
Autor:
Qinpei Deng, Lixiu He, Fangyan Xu, Qiaochun Deng, Tongze Xu, Junkai Jiang, Zhenxiang Hu, Jiaming Yang
Publikováno v:
Analytical Biochemistry. 668:115089
Autor:
Zhiren Zhang, Qiaren He, Wei Zhao, Yong Li, Jiaming Yang, Zhenxiang Hu, Xi Chen, Hua Peng, Yang-Xin Fu, Long Chen, Ligong Lu
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 14; Pages: 4164
Immune escape of emerging SARS-CoV-2 variants of concern (VOCs) and waning immunity over time following the primary series suggest the importance and necessity of booster shot of COVID-19 vaccines. With the aim to preliminarily evaluate the potential
Publikováno v:
Bulletin of Mathematical Biology. 84
The sudden outbreak of SARS-CoV-2 has caused the shortage of medical resources around the world, especially in developing countries and underdeveloped regions. With the continuous increase in the duration of this disease, the control of migration of